Review Articles Concerning Pulmonary Vascular Disease

Unilateral Pulmonary Arteriosclerosis Unusual Fibrous Connective Tissue Growth Associated; Review of Literature and Discussion of Possible Physiological Mechanisms Involved in These Changes

Scott R. Inkley, George R. AbbottWestern Reserve University and University Hospitals of Cleveland.United States Journal of the American Medical Association Internal MedicineJAMA Int Med 1961; 108: 903-915 https://doi:10.1001/archinte.1961.03620120087012 AbstractAn extensive fibrous connective tissue proliferation suggestive of retroperitoneal fibrosis or chronic mediastinitis is reported here. Aside from being the most extensive involvement that we can find […]

Unilateral Pulmonary Arteriosclerosis Unusual Fibrous Connective Tissue Growth Associated; Review of Literature and Discussion of Possible Physiological Mechanisms Involved in These Changes Read More »

Total Anomalous Pulmonary Venous Connection: Preoperative Anatomy, Physiology, Imaging, and Interventional Management of Postoperative Pulmonary Venous Obstruction

Matthew D. Files, Brian MorraySeattle Children’s Hospital.United States Seminars in Cardiothoracic and Vascular AnesthesiaSemin Cardiothorac Vasc Anesth 2017; 21: 123-131DOI: 10.1177/1089253216672442 AbstractTotal anomalous pulmonary venous connection refers to a spectrum of cardiac anomalies where the pulmonary veins fail to return to the left atrium and the pulmonary venous blood returns through a systemic vein or directly

Total Anomalous Pulmonary Venous Connection: Preoperative Anatomy, Physiology, Imaging, and Interventional Management of Postoperative Pulmonary Venous Obstruction Read More »

Bronchopulmonary dysplasia – Associated pulmonary hypertension: An updated review

Ahmed El-Saie, Nidhy P. Varghese, Melissa K. Webb, Natalie Villafranco, Bheru Gandhi, Milenka Cuevas Guaman, Binoy ShivannaChildren’s Mercy Hospital. Texas Children’s Hospital and Baylor College of Medicine. United States Seminars in PerinatologySemin Perinatol 2023; DOI: 10.1016/j.semperi.2023.151817 AbstractBronchopulmonary dysplasia (BPD) is the leading cause of chronic lung disease in infants and the commonest complication of prematurity. Advances

Bronchopulmonary dysplasia – Associated pulmonary hypertension: An updated review Read More »

Eisenmenger Syndrome: A Revisit of a Hidden but Catastrophic Disease

J. M. Chinawa, I. Arodiwe, J. T. Onyia, A. T. ChinawaUniversity of Nigeria/University of Nigeria Teaching Hospital. Enugu State University College of Medicine. Nigeria West African Journal of MedicineWest Afr J Med 2023; 40: 973-981DOI Not Available AbstractBackground: Eisenmenger syndrome (ES) is a rare condition seen in children with congenital heart disease (CHD). It is characterized

Eisenmenger Syndrome: A Revisit of a Hidden but Catastrophic Disease Read More »

Current and emerging pharmacotherapies for the treatment of pulmonary arterial hypertension in infants

Matthew F. Pizzuto, Matthew M. Laughon, Wesley M. JacksonUniversity of North Carolina at Chapel Hill.United States Expert Opinion on PharmacotherapyExpert Opin Pharmacother 2023; DOI: 10.1080/14656566.2023.2257598 AbstractIntroduction: Pulmonary hypertension (PH) is a complex condition that encompasses an array of underlying disease processes and affects a diverse population of infants, including those with congenital heart disease, congenital diaphragmatic hernia,

Current and emerging pharmacotherapies for the treatment of pulmonary arterial hypertension in infants Read More »

Congenital Heart Surgery Nomenclature and Database Project: pulmonary venous anomalies

J. René Herlong, James J. Jaggers, Ross M. UngerleiderDuke University Medical Center.United States Annals of Thoracic SurgeryAnn Thorac Surg 2000; 69 (4 Suppl): S56-S69DOI: 10.1016/s0003-4975(99)01237-0 AbstractThe extant nomenclature for pulmonary venous anomalies is reviewed for the purpose of establishing a unified reporting system. The subject was debated and reviewed by members of the STS-Congenital Heart Surgery

Congenital Heart Surgery Nomenclature and Database Project: pulmonary venous anomalies Read More »

Congenital and acquired pulmonary vein stenosis

Larry A. Latson, Lourdes R. PrietoCleveland Clinic FoundationUnited States CirculationCirculation 2007; 115: 103-108DOI: 10.1161/CIRCULATIONAHA.106.646166 AbstractNo Abstract Available CategorySegmental Pulmonary Venous Disease. Without a Focus on Pulmonary HypertensionSurgical and Catheter-mediated Interventions for Pulmonary Vascular DiseaseDiagnostic Testing for Pulmonary Vascular Disease. Non-invasive TestingDiagnostic Testing for Pulmonary Vascular Disease. Invasive TestingReview Articles Concerning Pulmonary Vascular Disease Age Focus: Pediatric Pulmonary Vascular Disease

Congenital and acquired pulmonary vein stenosis Read More »

The emerging roles of SUMOylation in pulmonary diseases

Xuyang Zheng, Lingqiao Wang, Zhen Zhang, Huifang TangThe Affiliated Hangzhou First People’s Hospital, Zhejiang Respiratory Drugs Research Laboratory and Zhejiang University School of Medicine. China Molecular MedicineMol Med 2023; 29: DOI: 10.1186/s10020-023-00719-1 AbstractSmall ubiquitin-like modifier mediated modification (SUMOylation) is a critical post-translational modification that has a broad spectrum of biological functions, including genome replication and repair,

The emerging roles of SUMOylation in pulmonary diseases Read More »

Imaging of pulmonary venous developmental anomalies

Jonathan R. Dillman, Sai G. Yarram, Ramiro J. HernandezUniversity of Michigan Health System and C. S. Mott Children’s Hospital.United States American Journal of RoentgenologyAJR Am J Roentgenol 2009; 192: 1272-1285DOI: 10.2214/AJR.08.1526 AbstractObjective: The purpose of this article is to review pulmonary venous embryology and to present the imaging findings of a variety of pulmonary venous developmental anomalies,

Imaging of pulmonary venous developmental anomalies Read More »

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s Innovative Drug Development Initiative – Group 3 Pulmonary Hypertension

Lucilla Piccari, Brian Allwood, Katerina Antoniou, Jonathan H. Chung, Paul M. Hassoun, Sylvia M. Nikkho, Rajan Saggar, Oksana A. Shlobin, Patrizio Vitulo, Steven D. Nathan, Stephen John WortHospital del Mar. Stellenbosch University and Tygerberg Hospital. University of Crete School of Medicine. The University of Chicago. Johns Hopkins University. Bayer AG. University of California Los Angeles

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s Innovative Drug Development Initiative – Group 3 Pulmonary Hypertension Read More »

Scroll to Top